Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.

Serotonergic ligands have proven effective drugs in the treatment of migraine, pain, obesity, and a wide range of psychiatric and neurological disorders. There is a clinical need for more highly 5-HT2 receptor subtype-selective ligands and the most attention has been given to the phenethylamine clas...

Full description

Bibliographic Details
Main Authors: Vignir Isberg, James Paine, Sebastian Leth-Petersen, Jesper L Kristensen, David E Gloriam
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3820707?pdf=render
_version_ 1818840959964676096
author Vignir Isberg
James Paine
Sebastian Leth-Petersen
Jesper L Kristensen
David E Gloriam
author_facet Vignir Isberg
James Paine
Sebastian Leth-Petersen
Jesper L Kristensen
David E Gloriam
author_sort Vignir Isberg
collection DOAJ
description Serotonergic ligands have proven effective drugs in the treatment of migraine, pain, obesity, and a wide range of psychiatric and neurological disorders. There is a clinical need for more highly 5-HT2 receptor subtype-selective ligands and the most attention has been given to the phenethylamine class. Conformationally constrained phenethylamine analogs have demonstrated that for optimal activity the free lone pair electrons of the 2-oxygen must be oriented syn and the 5-oxygen lone pairs anti relative to the ethylamine moiety. Also the ethyl linker has been constrained providing information about the bioactive conformation of the amine functionality. However, combined 1,2-constriction by cyclization has only been tested with one compound. Here, we present three new 1,2-cyclized phenylethylamines, 9-11, and describe their synthetic routes. Ligand docking in the 5-HT2B crystal structure showed that the 1,2-heterocyclized compounds can be accommodated in the binding site. Conformational analysis showed that 11 can only bind in a higher-energy conformation, which would explain its absent or low affinity. The amine and 2-oxygen interactions with D3.32 and S3.36, respectively, can form but shift the placement of the core scaffold. The constraints in 9-11 resulted in docking poses with the 4-bromine in closer vicinity to 5.46, which is polar only in the human 5-HT2A subtype, for which 9-11 have the lowest affinity. The new ligands, conformational analysis and docking expand the structure-activity relationships of constrained phenethylamines and contributes towards the development of 5-HT2 receptor subtype-selective ligands.
first_indexed 2024-12-19T04:18:29Z
format Article
id doaj.art-22e6dc693405453cbae88913e5682d3d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T04:18:29Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-22e6dc693405453cbae88913e5682d3d2022-12-21T20:36:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e7851510.1371/journal.pone.0078515Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.Vignir IsbergJames PaineSebastian Leth-PetersenJesper L KristensenDavid E GloriamSerotonergic ligands have proven effective drugs in the treatment of migraine, pain, obesity, and a wide range of psychiatric and neurological disorders. There is a clinical need for more highly 5-HT2 receptor subtype-selective ligands and the most attention has been given to the phenethylamine class. Conformationally constrained phenethylamine analogs have demonstrated that for optimal activity the free lone pair electrons of the 2-oxygen must be oriented syn and the 5-oxygen lone pairs anti relative to the ethylamine moiety. Also the ethyl linker has been constrained providing information about the bioactive conformation of the amine functionality. However, combined 1,2-constriction by cyclization has only been tested with one compound. Here, we present three new 1,2-cyclized phenylethylamines, 9-11, and describe their synthetic routes. Ligand docking in the 5-HT2B crystal structure showed that the 1,2-heterocyclized compounds can be accommodated in the binding site. Conformational analysis showed that 11 can only bind in a higher-energy conformation, which would explain its absent or low affinity. The amine and 2-oxygen interactions with D3.32 and S3.36, respectively, can form but shift the placement of the core scaffold. The constraints in 9-11 resulted in docking poses with the 4-bromine in closer vicinity to 5.46, which is polar only in the human 5-HT2A subtype, for which 9-11 have the lowest affinity. The new ligands, conformational analysis and docking expand the structure-activity relationships of constrained phenethylamines and contributes towards the development of 5-HT2 receptor subtype-selective ligands.http://europepmc.org/articles/PMC3820707?pdf=render
spellingShingle Vignir Isberg
James Paine
Sebastian Leth-Petersen
Jesper L Kristensen
David E Gloriam
Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.
PLoS ONE
title Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.
title_full Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.
title_fullStr Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.
title_full_unstemmed Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.
title_short Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.
title_sort structure activity relationships of constrained phenylethylamine ligands for the serotonin 5 ht2 receptors
url http://europepmc.org/articles/PMC3820707?pdf=render
work_keys_str_mv AT vignirisberg structureactivityrelationshipsofconstrainedphenylethylamineligandsfortheserotonin5ht2receptors
AT jamespaine structureactivityrelationshipsofconstrainedphenylethylamineligandsfortheserotonin5ht2receptors
AT sebastianlethpetersen structureactivityrelationshipsofconstrainedphenylethylamineligandsfortheserotonin5ht2receptors
AT jesperlkristensen structureactivityrelationshipsofconstrainedphenylethylamineligandsfortheserotonin5ht2receptors
AT davidegloriam structureactivityrelationshipsofconstrainedphenylethylamineligandsfortheserotonin5ht2receptors